← Home / Virax Biolabs Group Limited (VRAX)
Stock Analysis
Virax Biolabs Group Limited (VRAX)
VRAX
VRAX · Market data
4.33 -31.92%
52W Range Position
7%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-07-10 16:14 UTC
WOI Investment Thesis
Vulnerable
Confirmation improves above 4.38. Holding above 4.27 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
4.27
↗
Break Above
Confirmation improves above resistance.
4.38
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 4.27
What's Driving VRAX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 4.38 for confirmation and 4.27 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 4.27 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
51.9
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 4.27 and resistance around 8.76. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
VRAX · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Insufficient
⚖
Balance Sheet
Insufficient
Virax Biolabs Group Limited
Related Opportunities